top of page
Lab News
New Foundation Funding
We have received a generous grant from the Hearst Foundation to support preclinical and IND-enabling studies on our drug candidate for spinal cord injury, TMP-316.
Oct 21 min read
Our NCI RO1 received a 1.0 percentile score!!!
Our NCI R01 (Schatz, Ali) received a 1 percentile score. This grant aims to study the essential role of the cyclin-G associated kinase...
Apr 11, 20251 min read
New DoD Funding
The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...
Jan 31, 20251 min read
New State of Florida Funding
The Ali Lab, in collaboration with the Brambilla lab, received new funding from the State of Florida. The goal of this program is to...
Oct 29, 20241 min read
New DoD funding to tackle Neurotrauma research
A team from the Miami Project to Cure Paralysis, including the Ali Lab, Received DoD funding to tackle Neurotrauma research. Read more at...
Oct 29, 20241 min read
Our Blueprint Neurotherapeutics Network (BPN) program with NINDS/NIH transitioned to the UH3 Phase!
We are excited to share that our BPN program, aimed at developing a treatment for spinal cord injury (SCI), has transitioned from the UG3...
Mar 9, 20232 min read
R01 (NIH/NIDDK) grant application selected for funding!
The molecular mechanisms underlying nephrotic syndrome (NS) are unknown. In this three-way collaboration between Duke University...
Feb 2, 20231 min read
Our NIH BPN grant was selected for funding!
Our grant application (Ali, Lemmon, Bixby, Lee, Arizala) to the Blueprint Neurotherapeutics network was selected for funding! The goal of...
Feb 1, 20221 min read
bottom of page